Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes

Sponsor
Myomo (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05575674
Collaborator
Orthocare Innovations, LLC (Industry), Geauga Rehabilitation Engineering, Inc. (Other)
50
3
12
16.7
1.4

Study Details

Study Description

Brief Summary

The objective of this study is to retrospectively evaluate the outcomes and clinical benefits provided by this brace to adult patients with upper limb impairment or paralysis due to brachial plexus, stroke (CVA), spinal cord injury, or other neurological disease or injury.

Condition or Disease Intervention/Treatment Phase
  • Device: Myoelectric Elbow-Wrist-Hand Orthosis

Detailed Description

The objective of this study is to retrospectively evaluate the outcomes and clinical benefits provided by this brace to adult patients with upper limb impairment or paralysis due to brachial plexus, stroke (CVA), spinal cord injury, or other neurological disease or injury.

The primary result in this study is a comparison of the Disabilities of the Arm, Shoulder and Hand questionnaire results that were completed before and at least six months after receiving the MyoPro. A retrospective record review will be done to collect data regarding MyoPro user outcomes for individuals that received a MyoPro starting January 2021 and after. Additional data types such as demographics and clinical outcomes will be gathered. Participants may complete at least one follow-up session to record responses to additional inquiries from the research team.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes During Home Use
Actual Study Start Date :
Oct 5, 2022
Anticipated Primary Completion Date :
Oct 4, 2023
Anticipated Study Completion Date :
Oct 4, 2023

Outcome Measures

Primary Outcome Measures

  1. Disabilities of the Arm, Shoulder and Hand (DASH) [Pre-MyoPro]

    Validated outcome measure that asks an individual to self-report about the ability to perform certain upper limb activities. Questions are responded on a 5-point Likert scale.

  2. Disabilities of the Arm, Shoulder and Hand (DASH) [At least six months Post-MyoPro]

    Validated outcome measure that asks an individual to self-report about the ability to perform certain upper limb activities. Questions are responded on a 5-point Likert scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults, 65 years and older at the time of MyoPro delivery

  • Completed the DASH questionnaire at evaluation before receiving the MyoPro

  • Completed the DASH questionnaire at least six months after receiving the MyoPro

  • Has intact cognition

  • Able to clearly and verbally communicate in the English language

Exclusion Criteria:
  • Life-changing event(s) or change(s) in medical status that affected ability to use the MyoPro

  • Did not complete the DASH after receiving the MyoPro

  • Other conditions (e.g., cognitive issues) or circumstances that would preclude safe and/or effective participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Myomo, Inc. Boston Massachusetts United States 02114
2 Geauga Rehabilitation Engineering, Inc. Chardon Ohio United States 44024
3 Orthocare Innovations, LLC Edmonds Washington United States 98020

Sponsors and Collaborators

  • Myomo
  • Orthocare Innovations, LLC
  • Geauga Rehabilitation Engineering, Inc.

Investigators

  • Principal Investigator: Sarah Chang, Orthocare Innovations, LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Myomo
ClinicalTrials.gov Identifier:
NCT05575674
Other Study ID Numbers:
  • PRO-002
First Posted:
Oct 12, 2022
Last Update Posted:
Oct 27, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Myomo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2022